SCHEMBL3577937

SCHEMBL3577937

CCc1ccnc(N(C)C)c1C(N)=O

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDC7 O00311 2/20 0.39
CCNE1 P24864 1/20 0.39
CDK2 P24941 1/20 0.39
DBF4 Q9UBU7 1/20 0.39
KDM4E B2RXH2 3/20 0.35
ALDH1A1 P00352 3/20 0.35
CDK8 P49336 2/20 0.35
HTT P42858 1/20 0.35
CDK19 Q9BWU1 1/20 0.35
CYP1A2 P05177 1/20 0.33
POLB P06746 1/20 0.33
KDM5A P29375 1/20 0.32
KDM5C P41229 1/20 0.32
KDM5D Q9BY66 1/20 0.32
KDM4C Q9H3R0 1/20 0.32
KDM5B Q9UGL1 1/20 0.32
HPGD P15428 1/20 0.32
HSD17B10 Q99714 1/20 0.32
MAP4K4 O95819 1/20 0.32
PARP10 Q53GL7 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL440739 0.77 PDE3B (0.37) CDC7KDM4EALDH1A1CDK8CYP1A2
SCHEMBL14917466 0.77 NOS2 (0.43) CYP1A2POLBPARP10IKBKBKMT2A
Hydrochloric Acid SCHEMBL4651135 0.76 PDE3B (0.36) CDC7KDM4EALDH1A1CDK8CYP1A2
SCHEMBL18398498 0.75 NOS2 (0.37) CDC7CCNE1CDK2DBF4KDM4E
SCHEMBL2098279 0.73 POLB (0.41) CDC7CCNE1CDK2DBF4KDM4E
SCHEMBL3569660 0.72 KDM4E (0.43) KDM4EALDH1A1HPGDHSD17B10JAK3
SCHEMBL28207028 0.72 HTT (0.47) KDM4EALDH1A1HTTHPGDHSD17B10
SCHEMBL1533663 0.71 MEN1 (0.48) CDC7CCNE1CDK2DBF4KDM4E
SCHEMBL21966610 0.69 LMNA (0.31) KDM4ECYP1A2POLB
SCHEMBL16648947 0.69 KDM4E (0.42) CDC7CCNE1CDK2DBF4KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7678818-B2 Anthranilamide and 2-amino-heteroarene-carboxamide compounds HOFFMANN-LA ROCHE INC. (US) 2010-03-16 US disclosed
US-20070219261-A1 Anthranilamide and 2-amino-heteroarene-carboxamide compounds HOFFMANN-LA ROCHE INC. 2007-09-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070219261-A1 Anthranilamide and 2-amino-heteroarene-carboxamide compounds AADAT, AAAS, AADAC CDC7 3264/4885CCNE1 818/4885CDK2 110/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.